Stay updated on TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial page.

Latest updates to the TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s displayed revision/version marker has been updated from v3.5.2 to v3.5.3, with no apparent change to the underlying study content.SummaryDifference0.1%

- Check17 days agoChange DetectedAdded Revision: v3.5.2 and deleted Revision: v3.5.0.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check47 days agoChange DetectedRevision updated to v3.5.0. The previous v3.4.3 revision was removed.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 in the study documents section.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.4.2 was added and the funding-status notice (and the v3.4.1 note) was removed. These are general site updates that do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check90 days agoChange DetectedA site-wide notice about government funding lapse and NIH Clinical Center status has been added. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial page.